<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">2140979</PMID>
      <DateCompleted>
        <Year>1990</Year>
        <Month>07</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0012-6667</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>39</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>1990</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drugs</Title>
          <ISOAbbreviation>Drugs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions.</ArticleTitle>
        <Pagination>
          <StartPage>523</StartPage>
          <EndPage>551</EndPage>
          <MedlinePgn>523-51</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Nafarelin, a synthetic agonist of gonadotrophin-releasing hormone (GnRH) [luteinising hormone-releasing hormone (LH-RH); gonadorelin] appears likely to join the other GnRH analogues currently used in a range of conditions reliant on gonadotrophins or sex hormones. With repeated administration, the pituitary becomes desensitised, and gonadotrophin release, and therefore sex hormone synthesis, are inhibited. Nafarelin has proved to be comparable to danazol in the management of women with endometriosis, with fewer potentially harmful adverse effects. Nafarelin has also been used effectively in in vitro fertilisation programmes, and in hirsute women and those with uterine leiomyoma, particularly to induce preoperative fibroid shrinkage. The drug shrinks hypertrophic tissue in men with benign prostatic hyperplasia, although treatment would need to be maintained indefinitely and therefore should probably be reserved for those unsuitable for prostatectomy. Preliminary data suggest that nafarelin is equivalent to diethylstilbestrol (stilboestrol) in terms of disease-free survival in men with prostate cancer. As a reliable method of contraception, nafarelin gives unpredictable results in men and the promising results in women may be offset by hypoestrogenic side effects. Nafarelin may join other GnRH agonists which are now routinely used in the management of children with central or combined precocious puberty. Nafarelin is readily and rapidly absorbed following intranasal delivery, and is protected to some extent from enzymatic degradation. The resultant relatively long elimination half-life allows once- or twice-daily administration. Estrogen depletion accounts for the most common side effects associated with nafarelin, including hot flushes and vaginal dryness, which are mild and tolerable in most patients. Reversible resorption of trabecular bone can occur during nafarelin therapy, perhaps necessitating cyclical treatment to enable bone mass to recover. Nafarelin, therefore, looks likely to find a role in the treatment of women with endometriosis, and results achieved in other conditions dependent on the pituitary-gonadal axis are promising.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chrisp</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>ADIS Drug Information Services, Auckland, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goa</LastName>
            <ForeName>K L</ForeName>
            <Initials>KL</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>New Zealand</Country>
        <MedlineTA>Drugs</MedlineTA>
        <NlmUniqueID>7600076</NlmUniqueID>
        <ISSNLinking>0012-6667</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>1X0094V6JV</RegistryNumber>
          <NameOfSubstance UI="D017274">Nafarelin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>33515-09-2</RegistryNumber>
          <NameOfSubstance UI="D007987">Gonadotropin-Releasing Hormone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004700" MajorTopicYN="N">Endocrine System Diseases</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007987" MajorTopicYN="N">Gonadotropin-Releasing Hormone</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
          <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017274" MajorTopicYN="N">Nafarelin</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>74</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1990</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1990</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1990</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">2140979</ArticleId>
        <ArticleId IdType="doi">10.2165/00003495-199039040-00005</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Drugs. 1988 Jan;35(1):63-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3278879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Metab Dispos. 1985 Sep-Oct;13(5):560-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2865103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Invest. 1984 Jan;73(1):262-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6228566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 1984 Jun;58(6):1084-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6233295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Steroid Biochem. 1985 Nov;23(5B):849-54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2934581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 1988 Feb 25;318(8):485-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2963213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Obstet Gynecol. 1990 Feb;162(2):586-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2137976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Reprod Med. 1989 Dec;34(12 Suppl):1034-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2533619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fertil Steril. 1987 Jul;48(1):52-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2954864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fertil Steril. 1985 Jun;43(6):844-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3158549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fertil Steril. 1986 May;45(5):617-23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2938984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Reprod Med. 1989 Dec;34(12 Suppl):1039-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2533620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fertil Steril. 1985 Jul;44(1):96-101</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3924670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Pediatr. 1986 Dec;109(6):954-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2946840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 1988 Feb 25;318(8):512-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2963214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Androl. 1987 Jan-Feb;8(1):S17-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2951357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 1986 Dec;63(6):1334-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2946710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Med. 1987 Aug;83(2):359-61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2956882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 1988 Oct;67(4):701-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2971080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fertil Steril. 1985 Nov;44(5):583-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2932349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Endocrinol (Oxf). 1984 Feb;20(2):119-28</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6232019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Contraception. 1985 Oct;32(4):347-57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2934222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Reprod Med. 1989 Dec;34(12 Suppl):1021-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2533616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Endocrinol. 1974 Feb;60(2):305-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4593135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Endocrinol (Oxf). 1989 Sep;31(3):345-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2533526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Contraception. 1984 Aug;30(2):107-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6238805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Med Chem. 1982 Jul;25(7):795-801</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7050383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fertil Steril. 1985 Mar;43(3):361-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3156770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Obstet Gynecol. 1989 Jun;160(6):1454-9; discussion 1459-61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2525337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocr Rev. 1986 Feb;7(1):67-74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3514203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Pharm Sci. 1984 Sep;73(9):1294-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6238157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Androl. 1985 Jan-Feb;6(1):53-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3156111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Metab Dispos. 1985 Sep-Oct;13(5):566-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2865104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 1987 Jul;65(1):159-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2953749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Obstet Gynecol. 1988 Apr;158(4):903-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2966587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 1978 Nov 10;202(4368):631-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">100883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Exp Clin Endocrinol. 1988 Mar;92(3):252-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3075552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Contraception. 1985 Dec;32(6):531-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2936564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Obstet Gynecol. 1990 Feb;162(2):581-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2137975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obstet Gynecol. 1984 Aug;64(2):151-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6234483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Obstet Gynecol. 1990 Feb;162(2):593-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2137979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Pharmacol Ther. 1988 Sep;44(3):275-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2970910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 1985 May;60(5):998-1003</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3920237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Med Chem. 1981 Jun;24(6):688-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7019446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1990 Mar;39(3):399-437</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2109679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anal Biochem. 1984 Aug 15;141(1):10-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6238549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Obstet Gynecol. 1990 Feb;162(2):591-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2137978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 1986 Oct;63(4):854-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2943756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Reprod Med. 1989 Dec;34(12 Suppl):1025-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2533617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1990 Apr;39(4):502-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2190793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Obstet Gynecol. 1990 Feb;162(2):574-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2137972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Biol. 1986;63(5-6):218-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2939304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 1989 Dec;69(6):1097-103</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2531153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Biophys Res Commun. 1985 Mar 15;127(2):673-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3156598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 1987 Sep 3;317(10):599-604</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2441256</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
